Quantcast

Novavax Inc (NVAX) President and CEO Stanley C Erck Bought $113,000 of Shares


Shutterstock photo

President and CEO of Novavax Inc ( NVAX ) Stanley C Erck bought 100,000 shares of NVAX on 11/09/2017 at an average price of $1.13 a share. The total cost of this purchase was $113,000.

Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. Novavax Inc has a market cap of $354.390 million; its shares were traded at around $1.13 with and P/S ratio of 14.68. Novavax Inc had annual average EBITDA growth of 3.00% over the past ten years.

CEO Recent Trades:

  • President and CEO Stanley C Erck bought 100,000 shares of NVAX stock on 11/09/2017 at the average price of $1.13. The price of the stock has decreased by 0% since.


Directors and Officers Recent Trades:

  • President, R&D Gregory M Glenn bought 10,000 shares of NVAX stock on 11/09/2017 at the average price of $1.13. The price of the stock has decreased by 0% since.




click here

.



About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: Investing , Stocks
Referenced Symbols: NVAX


More from GuruFocus

Subscribe






GuruFocus
Contributor:

GuruFocus

Stock Picks, Portfolios








Research Brokers before you trade

Want to trade FX?





Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com